Cetuximab and biomarkers in non-small-cell lung carcinoma

Overview of attention for article published in Biologics: Targets & Therapy, July 2012

Altmetric Badge

About this Attention Score

In the top 25% of all research outputs scored by Altmetric
High Attention Score compared to outputs of the same age (81st percentile)
Good Attention Score compared to outputs of the same age and source (76th percentile)

Mentioned by

news: 1 news outlet

Readers on

mendeley: 38 Mendeley

So far, Altmetric has seen 1 news story.

標靶藥物是如何誕生的呢？讓癌症治療露出曙光的那些科學家們──唐獎生技醫藥獎 - PanSci 泛科學

Pansci, 30 Jul 2018

作者／李紀潔、羅鴻、泛科學編輯部從古埃及的紙莎草文獻到祕魯印加帝國的古木乃伊體內，都可見到人類飽受癌症侵擾的證據。而在醫療昌明的現代，癌症仍然高居國人十大死因的首位。人類與癌症纏鬥了數千年，難道沒有有效的治療方式，終結這長年來的惡夢嗎？在明星標靶藥物伊馬…